Prothena
PRTA
$20.96
Share price
1.90%
Change (1 day)
-60.55%
Change (1 year)
Categories
Prothena (PRTA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.69 B
According to Prothena's latest financial reports the company's total assets are $0.69 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Prothena - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.69 B | -8.13% |
| 2022-12-31 | $0.75 B | 24.4% |
| 2021-12-31 | $0.60 B | 83.01% |
| 2020-12-31 | $0.33 B | -20.58% |
| 2019-12-31 | $0.41 B | -15.94% |
| 2018-12-31 | $0.49 B | 0.5% |
| 2017-12-31 | $0.49 B | 7.9% |
| 2016-12-31 | $0.45 B | 19.4% |
| 2015-12-31 | $0.38 B | 26.67% |
| 2014-12-31 | $0.30 B | 66.72% |
| 2013-12-31 | $0.18 B | 41.09% |
| 2012-12-31 | $0.12 B | 3473.33% |
| 2011-12-31 | $3.61 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | $0.83 B | 19.43% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | 449.97% | 🇺🇸 USA |
 Alkermes ALKS | $2.13 B | 206.76% | 🇮🇪 Ireland |